BIO 2024 spotlight: Exothera's fast-track solutions for mRNA manufacturing
Darren Leva, chief business officer at Belgium-based CDMO Exothera, is at the forefront of the company’s efforts in advancing mRNA-based therapies.
Darren Leva, chief business officer at Belgium-based CDMO Exothera, is at the forefront of the company’s efforts in advancing mRNA-based therapies.
In what could be a significant leap for scientific research and biopharmaceuticals, DefiniGEN and Atelerix have unveiled a new collaboration that allows in vitro cell models to be shipped internationally without freezing or cryopreservation.
Bionova Scientific, an Asahi Kasei Group company and full-service biologics CDMO, has announced plans to expand into plasmid DNA (pDNA) production.